Cargando…

Targeted genome editing in acute lymphoblastic leukemia: a review

BACKGROUND: Genome editing technologies offers new opportunities for tackling diseases such as acute lymphoblastic leukemia (ALL) that have been beyond the reach of previous therapies. RESULTS: We show how the recent availability of genome-editing tools such as CRISPR-Cas9 are an important means of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Montaño, Adrián, Forero-Castro, Maribel, Hernández-Rivas, Jesús-María, García-Tuñón, Ignacio, Benito, Rocío
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050675/ https://www.ncbi.nlm.nih.gov/pubmed/30016959 http://dx.doi.org/10.1186/s12896-018-0455-9

Ejemplares similares

New Challenges in Targeting Signaling Pathways in Acute Lymphoblastic Leukemia by NGS Approaches: An Update
por: Montaño, Adrián, et al.
Publicado: (2018)

Integrated Genomic Analysis of Chromosomal Alterations and Mutations in B-Cell Acute Lymphoblastic Leukemia Reveals Distinct Genetic Profiles at Relapse
por: Forero-Castro, Maribel, et al.
Publicado: (2020)

ETV6/RUNX1 Fusion Gene Abrogation Decreases the Oncogenicity of Tumour Cells in a Preclinical Model of Acute Lymphoblastic Leukaemia
por: Montaño, Adrián, et al.
Publicado: (2020)

Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients
por: Montaño, Adrián, et al.
Publicado: (2020)

Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical Outcome
por: Forero-Castro, Maribel, et al.
Publicado: (2016)

Helpful Criteria When Implementing NGS Panels in Childhood Lymphoblastic Leukemia
por: Vega-Garcia, Nerea, et al.
Publicado: (2020)

The CRISPR/Cas9 system efficiently reverts the tumorigenic ability of BCR/ABL in vitro and in a xenograft model of chronic myeloid leukemia
por: García-Tuñón, Ignacio, et al.
Publicado: (2017)

Cholinergic Machinery as Relevant Target in Acute Lymphoblastic T Leukemia
por: Dobrovinskaya, Oxana, et al.
Publicado: (2016)

Advances in acute lymphoblastic leukemia genomics
por: Harrison, Christine J., et al.
Publicado: (2018)

Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia
por: de Barrios, Oriol, et al.
Publicado: (2021)

Targeting mTOR in Acute Lymphoblastic Leukemia
por: Simioni, Carolina, et al.
Publicado: (2019)

Targeting chemokines for acute lymphoblastic leukemia therapy
por: Hong, Zixi, et al.
Publicado: (2021)

Targeting Telomere Biology in Acute Lymphoblastic Leukemia
por: Karow, Axel, et al.
Publicado: (2021)

Epigenetic Priming in Childhood Acute Lymphoblastic Leukemia
por: Raboso-Gallego, Javier, et al.
Publicado: (2019)

Acute lymphoblastic leukemia
por: Schrappe, Martin
Publicado: (2018)

Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia
por: Forero-Castro, Maribel, et al.
Publicado: (2017)

Targeting IRAK1 in T-Cell acute lymphoblastic leukemia
por: Dussiau, Charles, et al.
Publicado: (2015)

Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia
por: Liu, Yu, et al.
Publicado: (2022)

Acute lymphoblastic leukemia in adults
por: Ribera, Josep-Maria
Publicado: (2011)

Pediatric acute lymphoblastic leukemia
por: Inaba, Hiroto, et al.
Publicado: (2020)

Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
por: Olivas-Aguirre, Miguel, et al.
Publicado: (2019)

Targeting survivin and p53 in pediatric acute lymphoblastic leukemia
por: Tyner, J W, et al.
Publicado: (2012)

Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia
por: Zhang, Cheng, et al.
Publicado: (2015)

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
por: Minieri, Valentina, et al.
Publicado: (2018)

Targeting PI3K Signaling in Acute Lymphoblastic Leukemia
por: Sanchez, Vanessa Edna, et al.
Publicado: (2019)

Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia
por: Porazzi, Patrizia, et al.
Publicado: (2021)

Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia
por: Xu, Huan, et al.
Publicado: (2021)

Targeting miR-126 in Ph+ acute lymphoblastic leukemia
por: Qiao, Junjing, et al.
Publicado: (2023)

Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics
por: Schwab, Claire, et al.
Publicado: (2018)

Biologic and Therapeutic Implications of Genomic Alterations in Acute Lymphoblastic Leukemia
por: Iacobucci, Ilaria, et al.
Publicado: (2021)

Latest Contributions of Genomics to T-Cell Acute Lymphoblastic Leukemia (T-ALL)
por: Genescà, Eulàlia, et al.
Publicado: (2022)

Retracted: Genomic and Clinical Analysis of Children with Acute Lymphoblastic Leukemia
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Relating genomic variation to drug response in childhood acute lymphoblastic leukemia by multiplexed targeted sequencing
por: Wesolowska, Agata, et al.
Publicado: (2010)

Venetoclax for Children and Adolescents with Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
por: Gibson, Amber, et al.
Publicado: (2021)

Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022)

The evolution of relapse of adult T cell acute lymphoblastic leukemia
por: Sentís, Inés, et al.
Publicado: (2020)

Comparative Genomic Hybridization and Transcriptome Sequencing Reveal Genes with Gain in Acute Lymphoblastic Leukemia: JUP Expression Emerges as a Survival-Related Gene
por: Zapata-García, Jessica Alejandra, et al.
Publicado: (2022)

Leukemia-Initiating Cells in T-Cell Acute Lymphoblastic Leukemia
por: Tan, Shi Hao, et al.
Publicado: (2017)

Acute lymphoblastic leukemia: age and biology
por: Foà, Robin
Publicado: (2011)

Pathogenesis and prognostication in acute lymphoblastic leukemia
por: Zuckerman, Tsila, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_rbl7ajv8vf43sfo7784jo2vefq